CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 239 enrolled
Drug / intervention
Patient-centered computerized tool +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00677898
NCT00677898N/ACompleted
CompareCT.gov

A Patient-Centered Approach to Improve Screening for Side Effects of SGAs

US Department of Veterans Affairs·interventional·Posted May 15, 2008·Updated Apr 27, 2015

In Brief

A clinical study evaluating Patient-centered computerized tool and Written educational materials for Schizophrenia and Psychotic Disorders. Completed, enrolled 239 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if individuals with serious mental illnesses exposed to a patient-centered computerized tool versus printed educational materials have higher rates of screening for the metabolic side effects of second-generation antipsychotic medications and different patterns of communication with their prescribers about screening.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia, Psychotic Disorders
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 15, 2008
Enrollment StartMar 1, 2010
Primary CompletionMar 1, 2012
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 18.1 years ago

Interventions

Patient-centered computerized toolbehavioral

A brief computer program that provides personalized health information to patients prescribed second-generation antipsychotic medications on adherence to guidelines for screening of metabolic side effects

Written educational materialsbehavioral

Printed information on the metabolic side effects of second-generation antipsychotic medications and general recommendations for screening